Addiction

Buprenorphine has shown to be effective and has the potential for widespread use to address the opioid epidemic. A subset of individuals with OUD have been acquiring it without a prescription.

An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, reviews the position of pharmacies in providing patients with opioid-induced constipation with the necessary medication to decrease hospitalization and cost of medication.

Experts in gastroenterology discuss the quality of life and perspective of patients with opioid-induced constipation.

Varenicline was efficacious at weeks 12, 24, and 52 of the trial compared with placebo in a smoking cessation program.

During the analysis, investigators became fascinated by how many patients entered the buprenorphine treatment program for OUD having already been taking the drug without a prescription.

William F. Peacock, MD; Conar Fitton, MD; and Neel Mehta, MD, explore the importance of early intervention and the overall challenges of ensuring that patients receive appropriate care for opioid-induced constipation.

A multidisciplinary panel discusses the presentation, frequency, and burden of opioid-induced constipation.

Dr William F. Peacock shares clinical pearls for the management of opioid-induced constipation.

Intravenous opioid use for VOC decreased by 52% in inpatient services between 2017-2018, while oral opioid use increased.

While young adults may be resistant to drinking interventions, improving sleep behavior can indirectly reduce hazardous drinking.

Since the delivery of these medications were disrupted during the pandemic, members of racial and ethnic minority groups experienced an increased risk of opioid overdose, compared with White individuals.

The director of NIDA discusses the unprecedented impact of the pandemic on overdose deaths—and how substance use disorder care may still reach greater capability when all is said and done.

Presence of chronic liver disease, prior use of gabapentin and being discharged to a long-term hospital or rehabilitation center are among some of the factors associated with a new opioid use disorder diagnosis.

Expert psychiatrist Dr. Timothy Fong explains the complexity of using marijuana as treatment in a primary care setting and shares advice on how to address it with patients.

The completion of this study concluded the planned clinical development program for nasal nalmefene and the company expects to file a New Drug Application in the second half of 2022.

Emergency medicine specialist urges hospitals to add methylnaltrexone to the hospital formulary after promising research shows the treatment's success with opioid-induced constipation.

methylnaltrexone is more effective, less costly, and can even keep some patients out of the hospital after being treated for opioid-induced constipation in the emergency department.

The NaV1.8 inhibitor VX-548 shows promising potential as a non-opioid acute pain treatment.

A summarization of the in-depth review, editorial and synopsis provided by multiple experts after revising the updates to the VA/DoD joint clinical practice guideline for substance use disorders.

Experts observed a significant increase in monthly overdose deaths during Spring 2020, before a gradual decrease to 2019 rates.

The CDC is encouraging public feedback on updated guideline recommendations for opioid prescribers for the first time since 2016.

Exposure to long-term prescription opioid therapy was linked to a 3.2-fold higher risk of HCV seroconversion compared to individuals who were prescription opioid-naïve or acute.

The University of Michigan School of Nursing DASH Center director discusses the impact and reach of adult prescription drug misuse.

A new survey analysis shows prescription opioid, stimulant, sedative and tranquilizer misuse is common by age 50, and is greatly associated with substance abuse disorder risk.